| Tenofovir-based preexposure prophylaxis for HIV infection among African women JM Marrazzo, G Ramjee, BA Richardson, K Gomez, N Mgodi, G Nair, ... New England Journal of Medicine 372 (6), 509-518, 2015 | 1468 | 2015 |
| Use of a vaginal ring containing dapivirine for HIV-1 prevention in women JM Baeten, T Palanee-Phillips, ER Brown, K Schwartz, LE Soto-Torres, ... New England Journal of Medicine 375 (22), 2121-2132, 2016 | 850 | 2016 |
| Successes and challenges of HIV prevention in men who have sex with men PS Sullivan, A Carballo-Diéguez, T Coates, SM Goodreau, I McGowan, ... The Lancet 380 (9839), 388-399, 2012 | 470 | 2012 |
| Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults P Barditch-Crovo, SG Deeks, A Collier, S Safrin, DF Coakley, M Miller, ... Antimicrobial agents and chemotherapy 45 (10), 2733-2739, 2001 | 419 | 2001 |
| Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue PA Anton, J Elliott, MA Poles, IM McGowan, J Matud, LE Hultin, ... Aids 14 (12), 1761-1765, 2000 | 226 | 2000 |
| Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel M Cranage, S Sharpe, C Herrera, A Cope, M Dennis, N Berry, C Ham, ... PLoS medicine 5 (8), e157, 2008 | 187 | 2008 |
| Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF NA Margot, E Isaacson, I McGowan, AK Cheng, RT Schooley, MD Miller Aids 16 (9), 1227-1235, 2002 | 179 | 2002 |
| Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals MA Poles, WJ Boscardin, J Elliott, P Taing, MMP Fuerst, I McGowan, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (1), 65-68, 2006 | 167 | 2006 |
| RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate PA Anton, RD Cranston, A Kashuba, CW Hendrix, NN Bumpus, ... AIDS research and human retroviruses 28 (11), 1412-1421, 2012 | 160 | 2012 |
| Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa KB Gurney, J Elliott, H Nassanian, C Song, E Soilleux, I McGowan, ... Journal of virology 79 (9), 5762-5773, 2005 | 157 | 2005 |
| Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation I McGowan, J Elliott, M Fuerst, P Taing, J Boscardin, M Poles, P Anton JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (2), 1228-1236, 2004 | 152 | 2004 |
| Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides PS Fletcher, J Elliott, JC Grivel, L Margolis, P Anton, I McGowan, ... Aids 20 (9), 1237-1245, 2006 | 149 | 2006 |
| Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004) I McGowan, K Gomez, K Bruder, I Febo, BA Chen, BA Richardson, ... Aids 25 (8), 1057-1064, 2011 | 144 | 2011 |
| HIV and mucosal barrier interactions: consequences for transmission and pathogenesis A Burgener, I McGowan, NR Klatt Current opinion in immunology 36, 22-30, 2015 | 137 | 2015 |
| The natural history of cryptosporidial diarrhoea in HIV-infected patients I Mc Gowan, AS Hawkins, IVD Weller Aids 7 (3), 349-354, 1993 | 120 | 1993 |
| A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007) I Mcgowan, C Hoesley, RD Cranston, P Andrew, L Janocko, JY Dai, ... PloS one 8 (4), e60147, 2013 | 107* | 2013 |
| Microbicides: a new frontier in HIV prevention I McGowan Biologicals 34 (4), 241-255, 2006 | 106 | 2006 |
| A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007) I Mcgowan, C Hoesley, RD Cranston, P Andrew, L Janocko, JY Dai, ... PloS one 8 (4), e60147, 2013 | 100 | 2013 |
| A tunable, biodegradable, thin-film polymer device as a long-acting implant delivering tenofovir alafenamide fumarate for HIV pre-exposure prophylaxis E Schlesinger, D Johengen, E Luecke, G Rothrock, I McGowan, ... Pharmaceutical research 33, 1649-1656, 2016 | 99 | 2016 |
| First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy PA Anton, T Saunders, J Elliott, E Khanukhova, R Dennis, A Adler, ... PLoS One 6 (9), e23243, 2011 | 97 | 2011 |
